TAIWAN HOPAX CHEMICALS MANUFACTURING CO., LTD. Financials Taiwan Hopax Chemicals Manufacturing Co., Ltd.
Equities
6509
TW0006509003
Specialty Chemicals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.65 TWD | +0.76% |
|
+1.41% | +1.41% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 3,294 | 3,258 | 4,850 | 11,882 | 7,096 | 6,783 |
| Enterprise Value (EV) 1 | 4,512 | 4,503 | 6,164 | 13,339 | 8,368 | 7,438 |
| P/E ratio | 19.5 x | 15.3 x | 17.2 x | 27.8 x | 12.1 x | 16.2 x |
| Yield | 3.21% | 3.78% | 3.57% | 1.82% | 3.37% | 3.2% |
| Capitalization / Revenue | 0.95 x | 0.87 x | 1.35 x | 2.51 x | 1.3 x | 1.5 x |
| EV / Revenue | 1.3 x | 1.2 x | 1.72 x | 2.82 x | 1.53 x | 1.65 x |
| EV / EBITDA | 10.5 x | 8.92 x | 9.93 x | 15.9 x | 8.28 x | 8.89 x |
| EV / FCF | 350 x | 28.1 x | 151 x | -216 x | 34.5 x | 9.69 x |
| FCF Yield | 0.29% | 3.56% | 0.66% | -0.46% | 2.89% | 10.3% |
| Price to Book | 1.21 x | 1.18 x | 1.68 x | 3.78 x | 1.99 x | 1.82 x |
| Nbr of stocks (in thousands) | 1,76,133 | 1,76,133 | 1,73,204 | 1,73,204 | 1,73,490 | 1,73,490 |
| Reference price 2 | 18.70 | 18.50 | 28.00 | 68.60 | 40.90 | 39.10 |
| Announcement Date | 30/03/19 | 30/03/20 | 31/03/21 | 31/03/22 | 30/03/23 | 01/04/24 |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 3,460 | 3,748 | 3,589 | 4,729 | 5,460 | 4,521 |
| EBITDA 1 | 427.7 | 504.6 | 620.7 | 839.9 | 1,010 | 836.9 |
| EBIT 1 | 203.6 | 289.4 | 383 | 564.3 | 736.4 | 540.8 |
| Operating Margin | 5.88% | 7.72% | 10.67% | 11.93% | 13.49% | 11.96% |
| Earnings before Tax (EBT) 1 | 215.1 | 273.4 | 377.8 | 563.4 | 770.2 | 534.2 |
| Net income 1 | 169 | 214 | 284.3 | 428.8 | 599.4 | 430 |
| Net margin | 4.89% | 5.71% | 7.92% | 9.07% | 10.98% | 9.51% |
| EPS 2 | 0.9596 | 1.210 | 1.630 | 2.470 | 3.379 | 2.416 |
| Free Cash Flow 1 | 12.89 | 160.3 | 40.93 | -61.75 | 242.2 | 767.6 |
| FCF margin | 0.37% | 4.28% | 1.14% | -1.31% | 4.44% | 16.98% |
| FCF Conversion (EBITDA) | 3.01% | 31.77% | 6.59% | - | 23.97% | 91.71% |
| FCF Conversion (Net income) | 7.62% | 74.92% | 14.4% | - | 40.42% | 178.51% |
| Dividend per Share 2 | 0.6000 | 0.7000 | 1.000 | 1.250 | 1.380 | 1.250 |
| Announcement Date | 30/03/19 | 30/03/20 | 31/03/21 | 31/03/22 | 30/03/23 | 01/04/24 |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1,218 | 1,245 | 1,314 | 1,457 | 1,272 | 654 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 2.847 x | 2.467 x | 2.117 x | 1.735 x | 1.259 x | 0.7818 x |
| Free Cash Flow 1 | 12.9 | 160 | 40.9 | -61.8 | 242 | 768 |
| ROE (net income / shareholders' equity) | 6.27% | 7.81% | 10.1% | 14.2% | 17.9% | 11.8% |
| ROA (Net income/ Total Assets) | 2.49% | 3.29% | 4.14% | 5.87% | 7.12% | 5.3% |
| Assets 1 | 6,784 | 6,512 | 6,860 | 7,306 | 8,420 | 8,114 |
| Book Value Per Share 2 | 15.50 | 15.70 | 16.60 | 18.10 | 20.50 | 21.50 |
| Cash Flow per Share 2 | 2.910 | 3.380 | 2.800 | 2.170 | 3.160 | 3.690 |
| Capex 1 | 289 | 343 | 368 | 248 | 337 | 271 |
| Capex / Sales | 8.36% | 9.16% | 10.25% | 5.25% | 6.17% | 5.99% |
| Announcement Date | 30/03/19 | 30/03/20 | 31/03/21 | 31/03/22 | 30/03/23 | 01/04/24 |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +1.41% | 21Cr | |
| +17.80% | 6.67TCr | |
| +2.92% | 4.98TCr | |
| +19.98% | 4.25TCr | |
| +20.88% | 2.64TCr | |
| +12.04% | 1.97TCr | |
| +1.27% | 1.72TCr | |
| -22.98% | 1.58TCr | |
| +2.77% | 1.56TCr | |
| -9.25% | 1.54TCr |
- Stock Market
- Equities
- 6509 Stock
- Financials Taiwan Hopax Chemicals Manufacturing Co., Ltd.
